Tetrahydropyran (THP)-substituted bicyclic-pyrimidinedione compounds
MYPI2025001954A0Undetermined Publication Date: 2020-04-29MYOKARDIA INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MYPI2025001954
- Authority / Receiving Office
- MY · MY
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2018-10-29
- Filing Date
- 2019-10-28
- Publication Date
- 2020-04-29
Abstract
The present disclosure provides novel tetrahydropyran (THP)-substituted bicyclic pyrimidinedione compounds that are useful for the treatment of hypertrophic cardiomyopathy (HCM), conditions associated with left ventricular hypertrophy, conditions associated with diastolic dysfunction, and / or symptoms associated thereof. The synthesis and characterization of the compounds is described, as well as methods for treating HCM and other forms of heart disease.
Need to check novelty before this filing date? Find Prior Art
